Home Other Building Blocks Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-

Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-

CAS No.:
57773-63-4
Catalog Number:
AG01DQA5
Molecular Formula:
C64H82N18O13
Molecular Weight:
1311.4487
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
Product Description
Catalog Number:
AG01DQA5
Chemical Name:
Luteinizing hormone-releasing factor (swine), 6-D-tryptophan-
CAS Number:
57773-63-4
Molecular Formula:
C64H82N18O13
Molecular Weight:
1311.4487
MDL Number:
MFCD00167541
IUPAC Name:
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(2-amino-2-oxoethyl)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
InChI:
InChI=1S/C64H82N18O13/c1-34(2)23-46(56(88)75-45(13-7-21-69-64(66)67)63(95)82-22-8-14-52(82)62(94)72-31-53(65)85)76-58(90)48(25-36-28-70-42-11-5-3-9-40(36)42)78-57(89)47(24-35-15-17-39(84)18-16-35)77-61(93)51(32-83)81-59(91)49(26-37-29-71-43-12-6-4-10-41(37)43)79-60(92)50(27-38-30-68-33-73-38)80-55(87)44-19-20-54(86)74-44/h3-6,9-12,15-18,28-30,33-34,44-52,70-71,83-84H,7-8,13-14,19-27,31-32H2,1-2H3,(H2,65,85)(H,68,73)(H,72,94)(H,74,86)(H,75,88)(H,76,90)(H,77,93)(H,78,89)(H,79,92)(H,80,87)(H,81,91)(H4,66,67,69)/t44-,45-,46-,47-,48+,49-,50-,51-,52-/m0/s1
InChI Key:
VXKHXGOKWPXYNA-PGBVPBMZSA-N
SMILES:
OC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)NCC(=O)N)CCCNC(=N)N)CC(C)C)Cc1c[nH]c2c1cccc2)Cc1ccc(cc1)O)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H]1CCC(=O)N1)Cc1[nH]cnc1
UNII:
08AN7WA2G0
Properties
Complexity:
2710  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
9  
Defined Bond Stereocenter Count:
0
Exact Mass:
1310.631g/mol
Formal Charge:
0
Heavy Atom Count:
95  
Hydrogen Bond Acceptor Count:
15  
Hydrogen Bond Donor Count:
17  
Isotope Atom Count:
0
Molecular Weight:
1311.473g/mol
Monoisotopic Mass:
1310.631g/mol
Rotatable Bond Count:
33  
Topological Polar Surface Area:
490A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
-0.3  
Literature
Title Journal
Characterization of 12 GnRH peptide agonists - a kinetic perspective. British journal of pharmacology 20160101
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. The New England journal of medicine 20140710
Correlation between oocyte number and follicular fluid concentration of pituitary adenylate cyclase-activating polypeptide (PACAP) in women after superovulation treatment. Journal of molecular neuroscience : MN 20121101
Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles. Human reproduction (Oxford, England) 20121101
The use of a slow release GnRH-agonist implant in female ferrets in season for oestrus suppression. Schweizer Archiv fur Tierheilkunde 20121101
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. The Journal of steroid biochemistry and molecular biology 20121001
A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20121001
Estrus induction in white rhinoceros (Ceratotherium simum). Theriogenology 20121001
Treatment with triptorelin in mentally disordered sex offenders: experience from a maximum-security hospital. Journal of clinical psychopharmacology 20121001
Ovarian activity reversibility after the use of deslorelin acetate as a short-term contraceptive in domestic queens. Theriogenology 20120901
Reversible suppression of sexual activity in tomcats with deslorelin implant. Theriogenology 20120901
Pharmacokinetic/pharmacodynamic model of the testosterone effects of triptorelin administered in sustained release formulations in patients with prostate cancer. The Journal of pharmacology and experimental therapeutics 20120901
[Change of the LHRH analogue in progressive castration-refractory prostate cancer]. Der Urologe. Ausg. A 20120901
Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V 20120801
Outcome of in vitro fertilization following stimulation with highly purified hMG or recombinant FSH in downregulated women of advanced reproductive age: a prospective, randomized and controlled trial. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20120701
Quantitation of slow release triptorelin in beagle dog plasma by liquid chromatography-tandem mass spectrometry. Journal of pharmaceutical and biomedical analysis 20120701
Open, multi-center, phase IV study to assess the efficacy and tolerability of triptorelin in Taiwanese patients with advanced prostate cancer. Journal of the Chinese Medical Association : JCMA 20120601
Interovulatory intervals in mares receiving deslorelin implants in Ireland (2009 to 2010). The Veterinary record 20120526
It's all in the timing: ovulation induction in the mare. The Veterinary record 20120526
Predominant suppression of follicle-stimulating hormone β-immunoreactivity after long-term treatment of intact and castrate adult male rats with the gonadotrophin-releasing hormone agonist deslorelin. Journal of neuroendocrinology 20120501
Cost-effectiveness analysis of degarelix for advanced hormone-dependent prostate cancer. BJU international 20120401
[Impact of androgen deprivation on the lipid profile and atherogenic risk in prostate cancer patients]. Actas urologicas espanolas 20120401
A case report: successful pregnancy after controlled ovarian hyperstimulation by using short-acting gonadotropin releasing hormone agonist only. Journal of assisted reproduction and genetics 20120401
Randomized trial using gonadotropin-releasing hormone agonist triptorelin for the preservation of ovarian function during (neo)adjuvant chemotherapy for breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210
Ovarian suppression for prevention of premature menopause and infertility: empty promise or effective therapy? Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20120210
Effects of the GnRH analogue deslorelin implants on reproduction in female domestic cats. Theriogenology 20120201
Reproductive seasonality and the effect of the GnRH agonist deslorelin as a contraceptive in captive male Black Flying-foxes (Pteropus alecto). Theriogenology 20120201
Triggering with GnRH agonist in oocyte-donation cycles: oestradiol monitoring is not necessary during ovarian stimulation. Reproductive biomedicine online 20120201
Urinary metabolite markers of precocious puberty. Molecular & cellular proteomics : MCP 20120101
[The use of deslorelin acetate (Suprelorin®) in companion animal medicine]. Schweizer Archiv fur Tierheilkunde 20120101
Central precocious puberty: treatment with triptorelin 11.25 mg. TheScientificWorldJournal 20120101
Oxytocin and vasopressin secretion from the rat hypothalamo-neurohypophysial system is stimulated by triptorelin. Endokrynologia Polska 20120101
The effects of cetrorelix and triptorelin on the viability and steroidogenesis of cultured human granulosa luteinized cells. In vivo (Athens, Greece) 20120101
Synthesis of triptorelin lactate catalyzed by lipase in organic media. International journal of molecular sciences 20120101
Experimental manipulation of fertility reveals potential lactation costs in a free-ranging marsupial. Biology letters 20111223
Formulation and evaluation of an in situ gel forming system for controlled delivery of triptorelin acetate. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences 20111120
The dynamics of endometrial growth and the triple layer appearance in three different controlled ovarian hyperstimulation protocols and their influence on IVF outcomes. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111101
Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20111101
Significance of pretreatment cardiovascular morbidity as a risk factor during treatment with parenteral oestrogen or combined androgen deprivation of 915 patients with metastasized prostate cancer: evaluation of cardiovascular events in a randomized trial. Scandinavian journal of urology and nephrology 20111101
Induction of fertile oestrus in the bitch using Deslorelin, a GnRH agonist. Theriogenology 20111101
Case of juvenile localized scleroderma with joint sclerosis and Sjögren's syndrome in a child with precocious puberty. The Journal of dermatology 20111001
Ovarian hyper-response to administration of an GnRH-agonist without gonadotropins. Journal of Korean medical science 20111001
[Clinical values of single or repeated triptorelin stimulating test in the differential diagnosis between idiopathic hypogonadotropic hypogonadism and constitutional delayed puberty]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae 20111001
Reproductive endocrinology: triptorelin ovarian suppression during breast cancer chemotherapy. Nature reviews. Endocrinology 20110920
A randomized trial (Irish clinical oncology research group 97-01) comparing short versus protracted neoadjuvant hormonal therapy before radiotherapy for localized prostate cancer. International journal of radiation oncology, biology, physics 20110901
Efficacy of long-term gonadotropin-releasing hormone analogue therapy to prevent recurrent catamenial penumothorax: a case report. European journal of obstetrics, gynecology, and reproductive biology 20110901
Effects of deslorelin implants on ovarian cysts in guinea pigs. Schweizer Archiv fur Tierheilkunde 20110901
Gonadotrophin-releasing hormone agonist protocols for pituitary suppression in assisted reproduction. The Cochrane database of systematic reviews 20110810
Use of a deslorelin implant to control aggression in a male bearded dragon (Pogona vitticeps). The Veterinary record 20110730
[Spontaneous complete remission in two patients with chronic lymphocytic leukemia]. Medicina clinica 20110723
Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal women with breast cancer: a randomized trial. JAMA 20110720
A comparison of the effect of short-term aromatase inhibitor (letrozole) and GnRH agonist (triptorelin) versus case control on pregnancy rate and symptom and sign recurrence after laparoscopic treatment of endometriosis. Archives of gynecology and obstetrics 20110701
Gonadal steroids and affective symptoms during in vitro fertilization: implication for reproductive mood disorders. Psychoneuroendocrinology 20110701
Spermatogenic and sperm quality differences in an experimental model of metabolic syndrome and hypogonadal hypogonadism. Reproduction (Cambridge, England) 20110701
Elevated GnRH receptor expression plus GnRH agonist treatment inhibits the growth of a subset of papillomavirus 18-immortalized human prostate cells. The Prostate 20110615
Regulation of AMH and SCF expression in human granulosa cells by GnRH agonist and antagonist. Die Pharmazie 20110601
Levels of the epidermal growth factor-like peptide amphiregulin in follicular fluid reflect the mode of triggering ovulation: a comparison between gonadotrophin-releasing hormone agonist and urinary human chorionic gonadotrophin. Fertility and sterility 20110501
Estrus induction in Beagle bitches with the GnRH-agonist implant containing 4.7 mg Deslorelin. Theriogenology 20110401
[Comparison of human chorionic gonadotropin (Pregnyl 10 000 IU i.m.) versus GnRH agonist (triptorelin 0,2 mg s.c.) for final oocytes maturation in the same egg donors--clinical and embryological characteristics]. Ceska gynekologie 20110401
Clinical efficacy of a GnRH-agonist implant containing 4.7 mg deslorelin, Suprelorin, regarding suppression of reproductive function in tomcats. Sandra.Pesch@vetmed.uni-giessen.de. Theriogenology 20110315
[Clinical values of triptorelin stimulating test in assessing hypothalamus-pituitary-gonad axis function in male patients with hypothalamus-pituitary-gonad axis disorders]. Zhonghua yi xue za zhi 20110315
Follicular cysts and prolonged oestrus in a female dog after administration of a deslorelin implant. New Zealand veterinary journal 20110301
Synchronization of ovulation and fertility in weaned sows treated with intravaginal triptorelin is influenced by timing of administration and follicle size. Theriogenology 20110115
Allopregnanolone levels decrease after gonadotropin-releasing hormone analog stimulation test in girls with central precocious puberty. Journal of endocrinological investigation 20110101
Bone loss in ovariectomized rats: dominant role for estrogen but apparently not for FSH. Journal of cellular biochemistry 20110101
Cost-effectiveness analysis of LHRH agonists in the treatment of metastatic prostate cancer in Italy. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research 20110101
Milder is better? Advantages and disadvantages of 'mild' ovarian stimulation for human in vitro fertilization. Reproductive biology and endocrinology : RB&E 20110101
Letrozole and norethisterone acetate versus letrozole and triptorelin in the treatment of endometriosis related pain symptoms: a randomized controlled trial. Reproductive biology and endocrinology : RB&E 20110101
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. BMC cancer 20110101
Low-dose human chorionic gonadotropin versus estradiol/progesterone luteal phase support in gonadotropin-releasing hormone agonist-triggered assisted reproductive technique cycles: understanding a new approach. Fertility and sterility 20101201
Triptorelin embonate: a 6-month formulation for prostate cancer. Expert opinion on pharmacotherapy 20101201
Use of hormonal protection for chemotherapy-induced gonadotoxicity. Clinical obstetrics and gynecology 20101201
Anabolic steroids purchased on the Internet as a cause of prolonged hypogonadotropic hypogonadism. Fertility and sterility 20101101
Tibolone as a hormone replacement in women with endometriosis after bilateral oophorectomy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20101101
LH (as HCG) and FSH surges for final oocyte maturation: sometimes it takes two to tango? Reproductive biomedicine online 20101101
Dual targeting of tumor and endothelial cells by gonadotropin-releasing hormone agonists to reduce melanoma angiogenesis. Endocrinology 20101001
Anti-Mullerian hormone dynamics during controlled ovarian hyperstimulation and optimal timing of measurement for outcome prediction. Human reproduction (Oxford, England) 20101001
Effects of long-term treatment with the GnrH agonist deslorelin (Suprelorin) on sexual function in boars. Theriogenology 20100915
The association between supra-physiological levels of estradiol and response patterns to experimental pain. European journal of pain (London, England) 20100901
Testosterone-induced modulation of nitric oxide-cGMP signaling pathway and androgenesis in the rat Leydig cells. Biology of reproduction 20100901
GnRH agonist administration at the time of implantation does not improve pregnancy outcome in intrauterine insemination cycles: a randomized controlled trial. Fertility and sterility 20100801
Death due to liver failure during endocrine therapy for premenopausal breast cancer. Acta oncologica (Stockholm, Sweden) 20100801
Endocrine, ovulatory and reproductive characteristics of sows treated with an intravaginal GnRH agonist. Animal reproduction science 20100701
GnRH agonist and GnRH antagonist protocols in ovarian stimulation: differential regulation pathway of aromatase expression in human granulosa cells. Reproductive biomedicine online 20100701
[Comparison of Alarelin and Triptorelin in the long-protocol ovulation induction in in vitro fertilization and embryo transfer]. Zhonghua nan ke xue = National journal of andrology 20100701
Ovarian hyperresponse to luteal phase GnRH-agonist administration. Archives of gynecology and obstetrics 20100601
Blood dripping from the penis of a German Shepherd dog. Australian veterinary journal 20100601
Triptorelin and sex offenders. Limited clinical data. Prescrire international 20100601
Phosphatase and tensin homolog gene inhibits the effect induced by gonadotropin-releasing hormone subtypes in human endometrial carcinoma cells. Chinese medical journal 20100505
Leydig-cell-tumor of the ovary that responded to GnRH-analogue administration - case report and review of the literature. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20100501
Comparative analysis of six months formulation of LHRH analogues for prostate cancer treatment. Archivos espanoles de urologia 20100501
Protective effect of a gonadotropin-releasing hormone analogue on chemotherapeutic agent-induced ovarian gonadotoxicity: a mouse model. European journal of obstetrics, gynecology, and reproductive biology 20100401
Cumulative live birth rates after GnRH-agonist triggering of final oocyte maturation in patients at risk of OHSS: a prospective, clinical cohort study. European journal of obstetrics, gynecology, and reproductive biology 20100401
Triptorelin improves intestinal symptoms among patients with colorectal endometriosis. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20100301
Effect of coasting on IVF cycle characteristics and outcome in short vs. long GnRH agonist protocols. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20100301
Triptorelin embonate (6-month formulation). Drugs 20100212
Comparison of four treatments to suppress ovarian activity in ferrets (Mustela putorius furo). The Veterinary record 20100116
A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertility and sterility 20100101
Regulation of gonadotropin-releasing hormone (GnRH) receptor-I expression in the pituitary and ovary by a GnRH agonist and antagonist. Reproductive sciences (Thousand Oaks, Calif.) 20100101
Anticancer activity of a new gonadotropin releasing hormone analogue. Biopolymers 20100101
Efficacy of gonadotropin-releasing hormone agonist and an extended-interval dosing regimen in the treatment of patients with adenomyosis and endometriosis. Gynecologic and obstetric investigation 20100101
[Efficiency of antagonist IVF cycle programming by estrogens]. Gynecologie, obstetrique & fertilite 20100101
Single dose GnRH agonist administration in the luteal phase of assisted reproduction cycles: is the effect dependent on the type of GnRH analogue used for pituitary suppression? Reproductive biomedicine online 20100101
Effect of treatment with cyproterone acetate on uterine bleeding at the beginning of GnRH analogue therapy in girls with idiopathic central precocious puberty. Hormone research in paediatrics 20100101
Administration of single-dose GnRH agonist in the luteal phase in ICSI cycles: a meta-analysis. Reproductive biology and endocrinology : RB&E 20100101
Modified natural cycle for in vitro fertilization and embryo transfer in normal ovarian responders. The Journal of international medical research 20100101
Use of increasing doses of a degradable Deslorelin implant to enhance uterine involution in postpartum lactating dairy cows. Animal reproduction science 20091201
Targeted drug and gene delivery systems for lung cancer therapy. Clinical cancer research : an official journal of the American Association for Cancer Research 20091201
[Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation]. La Tunisie medicale 20091201
Surface-functionalized nanoparticles for targeted gene delivery across nasal respiratory epithelium. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 20091101
Effect of a GnRH antagonist on GnRH agonist-implanted anestrous bitches. Theriogenology 20091015
The GnRH analogue triptorelin confers ovarian radio-protection to adult female rats. Mutation research 20091002
Influence of exogenous gonadotropin-releasing hormone on seasonal reproductive behavior of the coyote (Canis latrans). Theriogenology 20091001
Unintended pregnancy after gonadal failure chemoprevention with gonadotropin-releasing hormone agonist in women with hematologic malignancies. Fertility and sterility 20091001
Dose-response studies for pituitary and testicular function in male dogs treated with the GnRH superagonist, deslorelin. Reproduction in domestic animals = Zuchthygiene 20091001
GnRH agonist versus recombinant HCG in an oocyte donation programme: a randomized, prospective, controlled, assessor-blind study. Reproductive biomedicine online 20091001
[Virilization of a post-menopausal woman. Diagnostic and therapeutic considerations]. Endocrinologia y nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion 20091001
Morphological study of the effects of the GnRH superagonist deslorelin on the canine testis and prostate gland. Reproduction in domestic animals = Zuchthygiene 20091001
Health-related quality of life following surgical menopause and following gonadotrophin-releasing hormone analogue-induced pseudomenopause. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090901
Beneficial effect of luteal-phase gonadotropin-releasing hormone agonist administration on implantation rate after intracytoplasmic sperm injection. Taiwanese journal of obstetrics & gynecology 20090901
Stability of triptorelin in the presence of dermis and epidermis. International journal of pharmaceutics 20090813
Clinical use of deslorelin for the control of reproduction in the bitch. Reproduction in domestic animals = Zuchthygiene 20090701
Comparison between vestibular and subcutaneous insertion of deslorelin implants for oestrus induction in bitches. Reproduction in domestic animals = Zuchthygiene 20090701
Comparison of the effects of eFSH and deslorelin treatment regimes on ovarian stimulation and embryo production of donor mares in early vernal transition. Theriogenology 20090601
Luteinizing hormone-releasing hormone receptor-targeted deslorelin-docetaxel conjugate enhances efficacy of docetaxel in prostate cancer therapy. Molecular cancer therapeutics 20090601
Leiomyoma pseudocapsule after pre-surgical treatment with gonadotropin-releasing hormone agonists: relationship between clinical features and immunohistochemical changes. European journal of obstetrics, gynecology, and reproductive biology 20090501
Reproductive responses following postpartum suppression of ovarian follicular development with a deslorelin implant during summer heat stress in lactating dairy cows. Animal reproduction science 20090401
GnRH agonist versus GnRH antagonist in controlled ovarian hyperstimulation: their role in patients with an unfavorable prognosis a priori. Fertility and sterility 20090401
Ultrashort flare GnRH agonist combined with flexible multidose GnRH antagonist for patients with repeated IVF failures and poor embryo quality. Fertility and sterility 20090401
GnRH analogue for the prevention of ovarian hyperstimulation syndrome: a pilot study. Fertility and sterility 20090401
Immunolocalization of androgen receptor in the boar epididymis: the effect of GnRH agonist deslorelin. Reproduction in domestic animals = Zuchthygiene 20090401
What is the preferred GnRH analogue for polycystic ovary syndrome patients undergoing controlled ovarian hyperstimulation for in vitro fertilization? Fertility and sterility 20090401
RETRACTED: Treatment of nonparaphilic hypersexuality in men with a long-acting analog of gonadotropin-releasing hormone. The journal of sexual medicine 20090401
[Long GnRH agonist vs. GnRH antagonist protocol in randomized controlled trial in unselected patients--hormonal and cycle characteristics--pilot study]. Ceska gynekologie 20090401
In vitro fertilization cycle outcome after coasting in gonadotropin-releasing hormone (GnRH) agonist versus GnRH antagonist protocols. Fertility and sterility 20090201
Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study. Fertility and sterility 20090201
Estrogen suppression in premenopausal women following 8 weeks of treatment with exemestane and triptorelin versus triptorelin alone. Breast cancer research and treatment 20090201
Triggering with human chorionic gonadotropin or a gonadotropin-releasing hormone agonist in gonadotropin-releasing hormone antagonist-treated oocyte donor cycles: findings of a large retrospective cohort study. Fertility and sterility 20090201
Ovarian hyperstimulation syndrome following the sole administration of injectable gonadotropin-releasing hormone agonist (triptorelin) for the pituitary down-regulation and in vitro fertilization treatment: report of two cases. Archives of gynecology and obstetrics 20090201
Differential expression of LHRH-receptor in bovine nasal tissue and its role in deslorelin delivery. Peptides 20090201
Synthesis of novel Gn-RH analogues using Ugi-4MCR. Bioorganic & medicinal chemistry letters 20090201
Postpartum suppression of ovarian activity with a Deslorelin implant enhanced uterine involution in lactating dairy cows. Animal reproduction science 20090101
Triggering with HCG or GnRH agonist in GnRH antagonist treated oocyte donation cycles: a randomised clinical trial. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20090101
Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height. Neuroendocrinology 20090101
[Effect of gonadotropin-releasing hormone-I agonist and gonadotropin-releasing hormone-II on endometrial carcinoma cell lines with different states of PTEN]. Zhonghua fu chan ke za zhi 20090101
Growth outcome during GnRH agonist treatments for slowly progressive central precocious puberty. Neuroendocrinology 20090101
Subcutaneous gonadotropin-releasing hormone agonist (triptorelin) test for diagnosing precocious puberty. Hormone research 20090101
A favorable metabolic and antiatherogenic profile in carriers of CYP21A2 gene mutations supports the theory of a survival advantage in this population. Hormone research 20090101
Triptorelin 6-month formulation in the management of patients with locally advanced and metastatic prostate cancer: an open-label, non-comparative, multicentre, phase III study. Clinical drug investigation 20090101
Prepubertal serum inhibin B in cryptorchid infants and in monorchid boys with compensatory testicular hypertrophy. Fertility and sterility 20081201
Gonadotropin-releasing hormone inhibits pituitary adenylyl cyclase-activating polypeptide coupling to 3',5'-cyclic adenosine-5'-monophosphate pathway in LbetaT2 gonadotrope cells through novel protein kinase C isoforms and phosphorylation of pituitary adenylyl cyclase-activating polypeptide type I receptor. Endocrinology 20081201
Hormonal strategies for fertility preservation in patients receiving cyclophosphamide to treat glomerulonephritis: a nonrandomized trial and review of the literature. American journal of kidney diseases : the official journal of the National Kidney Foundation 20081101
[Efficacy and safety of long-acting gonadotropin-releasing hormone analogue in the treatment for metastatic prostate cancer]. Zhonghua wai ke za zhi [Chinese journal of surgery] 20081101
PSA kinetics provide improved prediction of survival in metastatic hormone-refractory prostate cancer. Urology 20081001
Preliminary evaluation of deslorelin, a GnRH agonist for contraception of the captive variable flying fox Pteropus hypomelanus. Contraception 20081001
A retrospective study of artificial insemination of 251 mares using chilled and fixed time frozen-thawed semen. Equine veterinary journal 20080901
Use of a gonadotropin releasing hormone agonist implant as an alternative for surgical castration in male ferrets (Mustela putorius furo). Theriogenology 20080715
Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs. Fertility and sterility 20080701
Factors determining normal adult height in girls with gonadotropin-dependent precocious puberty treated with depot gonadotropin-releasing hormone analogs. The Journal of clinical endocrinology and metabolism 20080701
Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats. Behavioural pharmacology 20080701
Gonadotropin-releasing hormone analog treatment for the prevention of treatment-related ovarian failure and infertility in women of reproductive age with Hodgkin lymphoma. Leukemia & lymphoma 20080601
Gray hair in children on triptorelin treatment. International journal of dermatology 20080601
Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency. Bioconjugate chemistry 20080601
Central precocious puberty due to hypothalamic hamartoma in a 7-month-old infant girl. European journal of pediatrics 20080501
Luteinizing hormone-dependent Cushing's syndrome in a pet ferret (Mustela putorius furo). Domestic animal endocrinology 20080401
Repeatability of preovulatory follicular diameter and uterine edema pattern in two consecutive cycles in the mare and how they are influenced by ovulation inductors. Theriogenology 20080401
Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles. Fertility and sterility 20080401
Prevention of ovarian function damage by a GnRH analogue during chemotherapy in Hodgkin lymphoma patients. Human reproduction (Oxford, England) 20080401
Influence of physiologic hormonal modification and of hormonal treatment in a patient with a history of migraine with aura. The journal of headache and pain 20080401
Side effects of pharmacotherapy on bone with long-acting gonadorelin agonist triptorelin for paraphilia. The journal of sexual medicine 20080301
GnRH agonist protocol administration in the luteal phase in ICSI-ET cycles stimulated with the long GnRH agonist protocol: a randomized, controlled double blind study. Human reproduction (Oxford, England) 20080301
Morphofunctional alterations in testicular cells of deslorelin-treated boars: an immunohistochemical study. Journal of experimental zoology. Part A, Ecological genetics and physiology 20080301
Luteal phase support with GnRH-a improves implantation and pregnancy rates in IVF cycles with endometrium of <or=7 mm on day of egg retrieval. Human fertility (Cambridge, England) 20080301
A randomized study comparing triptorelin or expectant management following conservative laparoscopic surgery for symptomatic stage III-IV endometriosis. European journal of obstetrics, gynecology, and reproductive biology 20080201
Effect of a gonadotrophin-releasing hormone analogue on lung function in lymphangioleiomyomatosis. Chest 20080201
Endocrine effects of adjuvant letrozole + triptorelin compared with tamoxifen + triptorelin in premenopausal patients with early breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 20080110
Height gain with combined growth hormone and gonadotropin-releasing hormone analog therapy in two pubertal siblings with a growth hormone-releasing hormone receptor mutation. The Journal of clinical endocrinology and metabolism 20080101
Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20080101
Endocrine modifications associated with final oocyte maturation with gonadotropin-releasing hormone agonists vs. human chorionic gonadotropin in women undergoing intrauterine insemination. The Journal of reproductive medicine 20080101
The development of a testosterone stimulation test in the Virginia opossum (Didelphis virginiana) and its use in evaluating deslorelin contraception. Reproduction, fertility, and development 20080101
Dephosphorylation of cancer protein by tyrosine phosphatases in response to analogs of luteinizing hormone-releasing hormone and somatostatin. Anticancer research 20080101
Leuprorelin, triptorelin: new indications. Locally advanced prostate cancer: minimally assessed me-toos. Prescrire international 20071201
Evaluation of three equine FSH superovulation protocols in mares. Animal reproduction science 20071101
Effect of the microencapsulation of nanoparticles on the reduction of burst release. International journal of pharmaceutics 20071101
Ovulation induced by mucosa vaginal absorption of buserelin and triptorelin in rabbit. Theriogenology 20071015
GnRH agonist and antagonist protocols for stage I-II endometriosis and endometrioma in in vitro fertilization/intracytoplasmic sperm injection cycles. Fertility and sterility 20071001
The effects of gonadotropin releasing hormone analogue therapy on girls with gonadotropin-dependent precocious puberty. Journal of the Formosan Medical Association = Taiwan yi zhi 20071001
Clinical outcome with half-dose depot triptorelin is the same as reduced-dose daily buserelin in a long protocol of controlled ovarian stimulation for ICSI/embryo transfer: a randomized double-blind clinical trial (NCT00461916). Human reproduction (Oxford, England) 20070901
Long-term follow-up of a neoadjuvant chemohormonal taxane-based phase II trial before radical prostatectomy in patients with non-metastatic high-risk prostate cancer. BJU international 20070801
Serum sex hormone-binding globulin levels in healthy children and girls with precocious puberty before and during gonadotropin-releasing hormone agonist treatment. The Journal of clinical endocrinology and metabolism 20070801
Population pharmacokinetic/pharmacodynamic (PK/PD) modelling of the hypothalamic-pituitary-gonadal axis following treatment with GnRH analogues. British journal of clinical pharmacology 20070601
Chronic treatment of male tammar wallabies with deslorelin implants during pouch life: effects on development, puberty, and reproduction in adulthood. Biology of reproduction 20070601
[Mediastinal lymph nodes during the course of a metastatic prostate cancer]. Actas urologicas espanolas 20070601
Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study. Human reproduction (Oxford, England) 20070501
Early follicular progesterone concentrations and in vitro fertilization pregnancy outcomes. Fertility and sterility 20070401
Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology (Amsterdam, Netherlands) 20070401
[Multicentre randomized trial comparing triptorelin medical castration versus surgical castration in the treatment of locally advanced or metastatic prostate cancer]. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 20070401
GnRH agonist treatment in girls with precocious puberty does not compromise post-pubertal uterine size. Human reproduction (Oxford, England) 20070301
Use of gonadotropin-releasing hormone agonists in patients with Hodgkin's disease for preservation of ovarian function and reduction of gonadotoxicity related to chemotherapy. Fertility and sterility 20070301
Thyroid outcome during long-term gonadotropin-releasing hormone agonist treatments for idiopathic precocious puberty. The Journal of adolescent health : official publication of the Society for Adolescent Medicine 20070301
Efficacy of hormonal manipulation in lymphangioleiomyomatosis. A 20-year-experience in 36 patients. Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG 20070301
The effect of a GnRH agonist on cryopreserved human ovarian grafts in severe combined immunodeficient mice. Reproduction (Cambridge, England) 20070201
The influence of estradiol/follicle and estradiol/oocyte ratios on the outcome of controlled ovarian stimulation for in vitro fertilization. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070201
Dyspareunia and quality of sex life after laparoscopic excision of endometriosis and postoperative administration of triptorelin. Fertility and sterility 20070101
Anti-androgenic treatment of obsessive-compulsive disorder: an open-label clinical trial of the long-acting gonadotropin-releasing hormone analogue triptorelin. International clinical psychopharmacology 20070101
[Side effects of treatment with the long-acting gonadorelin agonist triptorelin in a case of paraphilia]. Tijdschrift voor psychiatrie 20070101
Controlled ovarian hyperstimulation using multi-dose gonadotropin-releasing hormone (GnRH) antagonist results in less systemic inflammation than the GnRH-agonist long protocol. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20070101
Pituitary and testicular endocrine responses to exogenous gonadotrophin-releasing hormone (GnRH) and luteinising hormone in male dogs treated with GnRH agonist implants. Reproduction, fertility, and development 20070101
Effects of deslorelin implants on reproduction in the common brushtail possum (Trichosurus vulpecula). Reproduction, fertility, and development 20070101
Successful timing of ovulation using deslorelin (Ovuplant) is labour-saving in mares aimed for single ai with frozen semen. Reproduction in domestic animals = Zuchthygiene 20061201
GnRH-II agonist [D-Lys6]GnRH-II inhibits the EGF-induced mitogenic signal transduction in human endometrial and ovarian cancer cells. International journal of oncology 20061101
[Triptorelin therapy in girls with central precocious puberty increases body mass index]. Anales de pediatria (Barcelona, Spain : 2003) 20061101
[Central precocious puberty is associated with a high prevalence of organic disease]. Anales de pediatria (Barcelona, Spain : 2003) 20061101
Luteinizing hormone-releasing hormone agonist and transferrin functionalizations enhance nanoparticle delivery in a novel bovine ex vivo eye model. Molecular vision 20061017
GnRH-agonist induction of fertile estrus with either natural mating or artificial insemination, followed by birth of pups in gray wolves (Canis lupus). Theriogenology 20061001
The influence of exogenous progestin on the occurrence of proestrous or estrous signs, plasma concentrations of luteinizing hormone and estradiol in deslorelin (GnRH agonist) treated anestrous bitches. Theriogenology 20061001
The use of deslorelin implants for the synchronization of estrous in diestrous bitches. Theriogenology 20061001
Failure of hCG to support luteal function in bitches after estrus induction using deslorelin implants. Theriogenology 20061001
Repeated use of the GnRH analogue deslorelin to down-regulate reproduction in male cheetahs (Acinonyx jubatus). Theriogenology 20061001
A review of advances in the use of the GnRH agonist deslorelin in control of reproduction. Theriogenology 20061001
Actions of gonadotropin-releasing hormone analogues in pituitary gonadotrophs and their modulation by ovarian steroids. The Journal of steroid biochemistry and molecular biology 20061001
Beneficial effect of luteal-phase GnRH agonist administration on embryo implantation after ICSI in both GnRH agonist- and antagonist-treated ovarian stimulation cycles. Human reproduction (Oxford, England) 20061001
Prevention of severe menorrhagia in oncology patients with treatment-induced thrombocytopenia by luteinizing hormone-releasing hormone agonist and depo-medroxyprogesterone acetate. Cancer 20061001
Reproductive outcome in patients treated and not treated for idiopathic early puberty: long-term results of a randomized trial in adults. The Journal of pediatrics 20061001
Immunocytogenetic effects of gonadotropin releasing hormone analogue: Triptorelin Pamoate (Decapeptyl) during in vitro fertilization treatment. Human & experimental toxicology 20061001
[Effect of triptorelin and an extended-interval dosing regimen in the treatment of patients with endometriosis and adenomyoma]. Zhonghua fu chan ke za zhi 20061001
Comparison between a GnRH antagonist and a GnRH agonist flare-up protocol in oocyte donors: a randomized clinical trial. Human reproduction (Oxford, England) 20060901
Comparison of follicular fluid IGF-I, IGF-II, IGFBP-3, IGFBP-4 and PAPP-A concentrations and their ratios between GnRH agonist and GnRH antagonist protocols for controlled ovarian stimulation in IVF-embryo transfer patients. Human reproduction (Oxford, England) 20060801
Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial. Annals of oncology : official journal of the European Society for Medical Oncology 20060801
Impact of neoadjuvant hormonal therapy on dose-volume histograms in patients with localized prostate cancer under radical radiation therapy. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 20060801
Treatment of central precocious puberty with triptorelin 11.25 mg depot formulation. Journal of pediatric endocrinology & metabolism : JPEM 20060801
Regulation of GnRH I receptor gene expression by the GnRH agonist triptorelin, estradiol, and progesterone in the gonadotroph-derived cell line alphaT3-1. Endocrine 20060801
Long-term suppression of fertility in female giraffe using the GnRH agonist deslorelin as a long-acting implant. Theriogenology 20060715
Combination therapy using LHRH and somatostatin analogues plus dexamethasone in androgen ablation refractory prostate cancer patients with bone involvement: a bench to bedside approach. Expert opinion on investigational drugs 20060701
Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. Journal of the National Medical Association 20060701
Combination growth hormone and gonadotropin releasing hormone analog therapy in 11beta-hydroxylase deficiency. Journal of pediatric endocrinology & metabolism : JPEM 20060601
The use of a deslorelin implant (GnRH agonist) during the late embryonic period to reduce pregnancy loss. Theriogenology 20060501
Pituitary desensitization for eight weeks after the administration of two distinct gonadotrophin-releasing hormone agonists. European journal of obstetrics, gynecology, and reproductive biology 20060501
Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development. European journal of obstetrics, gynecology, and reproductive biology 20060501
Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial. Human reproduction (Oxford, England) 20060501
IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol. Journal of endocrinological investigation 20060501
[Endometriosis]. Nihon rinsho. Japanese journal of clinical medicine 20060401
[Anti-tumor effects of GnRH analogs in gynecological cancers]. Nihon rinsho. Japanese journal of clinical medicine 20060401
Endocrine, morphological, and cytological effects of a depot GnRH agonist in bovine. Animal reproduction science 20060301
Serum and follicular fluid levels of soluble Fas and soluble Fas ligand in IVF cycles. European journal of obstetrics, gynecology, and reproductive biology 20060301
Spontaneous remission of acute myeloid leukemia associated with GnRH agonist treatment. Leukemia & lymphoma 20060301
Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207. The Prostate 20060201
Short communication: suppression of estrous cycles in lactating cows has no effect on milk production. Journal of dairy science 20060201
Levels of apoptosis in human granulosa cells seem to be comparable after therapy with a gonadotropin-releasing hormone agonist or antagonist. Fertility and sterility 20060201
Administration of alternate day triptorelin for controlled ovarian hyperstimulation is cost effective. Fertility and sterility 20060201
Short-term progestin treatments prevent estrous induction by a GnRH agonist implant in anestrous bitches. Theriogenology 20060120
Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty. European journal of endocrinology 20060101
Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer. The Journal of urology 20060101
[Precocious puberty and von Recklinghausen's disease]. Wiadomosci lekarskie (Warsaw, Poland : 1960) 20060101
Effects of a preovulatory administered depot gonadotrophin-releasing hormone agonist on reproductive hormone levels and pregnancy outcome in gilts. Reproduction, fertility, and development 20060101
Efficacy of subcutaneous administration of gonadotropin-releasing hormone agonist on idiopathic central precocious puberty. Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban 20060101
[Ovarian hyperstimulation induced by a GnRH agonist. About one case]. Gynecologie, obstetrique & fertilite 20051201
Criteria of a successful coasting protocol for the prevention of severe ovarian hyperstimulation syndrome. Human reproduction (Oxford, England) 20051101
Does plasma insulin level affect ovarian response to exogenous administration of follicle-stimulating hormone in women without polycystic ovary syndrome? Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20051101
A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists. Human reproduction (Oxford, England) 20051001
Transdermal iontophoretic delivery of triptorelin in vitro. Journal of pharmaceutical sciences 20051001
Analogs of GnRH-I and GnRH-II inhibit epidermal growth factor-induced signal transduction and resensitize resistant human breast cancer cells to 4OH-tamoxifen. European journal of endocrinology 20051001
[Pharmacokinetics and pharmacodynamics of triptorelin]. Annales d'urologie 20051001
[Treatment of precocious puberty by GnRH agonists]. Annales d'urologie 20051001
A preliminary study on reduced dose (33 or 25 microg) gonadotropin-releasing hormone agonist long protocol for multifollicular ovarian stimulation in patients with high basal serum follicle-stimulating hormone levels undergoing in vitro fertilization-embryo transfer. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20051001
Testicular development of Zebu bulls after chronic treatment with a gonadotropin-releasing hormone agonist. Journal of animal science 20050901
Different effects of agonistic vs. antagonistic gnrh-analogues (triptorelin vs. cetrorelix) on bone modeling and remodeling in peripubertal female rats. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20050901
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. Endocrinology 20050801
GnRH analogues--agonists and antagonists. Animal reproduction science 20050801
Differences in serum LH and FSH levels using depot or daily GnRH agonists in controlled ovarian stimulation: influence on ovarian response and outcome of ART. Journal of assisted reproduction and genetics 20050801
Antagonist and agonist binding models of the human gonadotropin-releasing hormone receptor. Biochemical and biophysical research communications 20050729
PSA bouncing after short term androgen deprivation and 3D-conformal radiotherapy for localized prostate adenocarcinoma and the relationship with the kinetics of testosterone. European urology 20050701
[Clinical trial on the effectiveness and safety of triptorelin in treatment of uterine leiomyoma]. Zhonghua fu chan ke za zhi 20050701
[Influence of serum levels of luteinizing hormone during controlled ovarian hyperstimulation on the results of IVF cycle]. Ceska gynekologie 20050701
Immunosuppression with a combination of pg490-88 and a subtherapeutic dose of FK506 in a canine renal allograft model. Transplantation 20050615
GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study. Human reproduction (Oxford, England) 20050601
Restoration patterns for luteinising hormone and ovarian function following treatment with GnRH agonist implants (deslorelin) for 7, 14 or 21 days in cycling dairy cows. Animal reproduction science 20050601
Clinical and endocrine responses to treatment with deslorelin acetate implants in ferrets with adrenocortical disease. American journal of veterinary research 20050501
Basal and stimulation day 5 anti-Mullerian hormone serum concentrations as predictors of ovarian response and pregnancy in assisted reproductive technology cycles stimulated with gonadotropin-releasing hormone agonist--gonadotropin treatment. Human reproduction (Oxford, England) 20050401
Changes in cytokine levels of patients with ovarian endometriosis after treatment with gonadotropin-releasing hormone analogue, ultrasound-guided drainage, and intracystic recombinant interleukin-2. Fertility and sterility 20050401
Early cessation of triptorelin in in vitro fertilization: a double-blind, randomized study. Fertility and sterility 20050401
Serum luteinizing hormone, follicle-stimulating hormone and oestradiol pattern in women undergoing pituitary suppression with different gonadotrophin-releasing hormone analogue protocols for assisted reproduction. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20050401
Randomized trial of adjuvant ovarian suppression in 926 premenopausal patients with early breast cancer treated with adjuvant chemotherapy. Annals of oncology : official journal of the European Society for Medical Oncology 20050301
Effect of halving the daily dose of triptorelin at the start of ovarian stimulation on hormone serum levels and the outcome of in vitro fertilization. Fertility and sterility 20050301
Long-term effects of deslorelin implants on reproduction in the female tammar wallaby (Macropus eugenii). Reproduction (Cambridge, England) 20050301
Reproductive performance of early postpartum Holstein cows where oestrus was synchronised following chronic GnRH agonist treatment. Australian veterinary journal 20050301
[Hormonal suppression and sexual development in children with central precocious puberty in the first treatment cycle 12 weeks after injection of triptoreline 11.25 mg (Diphereline S. R. 11.25 mg): a pilot study]. Ceska gynekologie 20050301
Observations on the reproductive effects of once or twice weekly injections for 6 weeks of the GnRH agonist deslorelin in the cow. Animal reproduction science 20050201
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Molecular human reproduction 20050201
Gonadotropin-releasing hormone receptor-targeted gene therapy of gynecologic cancers. Molecular cancer therapeutics 20050201
[Treatment of central precocious puberty with Gonadotropin-Releasing Hormone agonist (triptorelin) in girls: breast development, skeletal maturation, height and weight evolution during and after treatment]. Revue medicale de Bruxelles 20050201
Single and repeated GnRH agonist stimulation tests compared with basal markers of ovarian reserve in the prediction of outcome in IVF. Journal of assisted reproduction and genetics 20050201
Oestradiol-17beta responsiveness, plasma LH profiles, pituitary LH and FSH concentrations in long-term ovariectomised Holstein cows at 24 h, 48 h and 21 days following treatment with an absorbable GnRH agonist implant. Animal reproduction science 20050101
[Pharmacodynamics of triptorelin]. La Revue du praticien 20050101
Chronic cystic ovarian disease in a Holstein cow. Australian veterinary journal 20050101
Antagonistic and agonistic GnRH analogue treatment of precocious puberty: tracking gonadotropin concentrations in urine. Hormone research 20050101
Neridronate prevents bone loss in patients receiving androgen deprivation therapy for prostate cancer. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 20041101
Treatment of endometrial stromal sarcoma with a gonadotropin-releasing hormone analogue. Obstetrics and gynecology 20041101
A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol. Fertility and sterility 20041101
Gonadotropin-releasing hormone (GnRH) agonist triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells. European journal of endocrinology 20041101
Extended coasting duration exerts a negative impact on IVF cycle outcome due to premature luteinization. Reproductive biomedicine online 20041101
[Triptorelin. A hormonal treatment for prostate cancer]. Revue de l'infirmiere 20041101
[Clinical study of subcutaneous administration of gonadotropin-releasing hormone agonist every six weeks in girls with idiopathic central precocious puberty]. Zhonghua er ke za zhi = Chinese journal of pediatrics 20041101
Half-dose depot triptorelin in pituitary suppression for multiple ovarian stimulation in assisted reproduction technology: a randomized study. Human reproduction (Oxford, England) 20041001
Gonadotropin releasing hormone antagonists and cryopreservation outcome: a review. Archives of gynecology and obstetrics 20040901
Effects of a new injectable short-term release deslorelin in foal-heat mares. Theriogenology 20040901
Estimation of the follicle-stimulating hormone (FSH) threshold for initiating the final stages of follicular development in women with elevated FSH levels in the early follicular phase. Fertility and sterility 20040901
Deslorelin on Day 8 or 12 postovulation does not luteinize follicles during an artificially maintained diestrous phase in the mare. Theriogenology 20040701
GnRH analogs: depot versus short formulations. European journal of obstetrics, gynecology, and reproductive biology 20040701
Transport of deslorelin, an LHRH agonist, is vectorial and exhibits regional variation in excised bovine nasal tissue. The Journal of pharmacy and pharmacology 20040701
Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor. European journal of endocrinology 20040701
Luteal phase defects following agonist-triggered ovulation: a patient-dependent response. Reproductive biomedicine online 20040701
Pulmonary delivery of deslorelin: large-porous PLGA particles and HPbetaCD complexes. Pharmaceutical research 20040701
Association of inhibin B serum levels with parameters of follicular response in a randomized controlled trial comparing gnRH agonist versus antagonist protocols for ovarian hyperstimulation. Journal of assisted reproduction and genetics 20040701
Effects of a gonadotropin-releasing hormone agonist implant on reproduction in a male marsupial, Macropus eugenii. Biology of reproduction 20040601
An open and randomized study comparing the efficacy of standard danazol and modified triptorelin regimens for postoperative disease management of moderate to severe endometriosis. Fertility and sterility 20040601
Evidence for LHRH-receptor expression in human airway epithelial (Calu-3) cells and its role in the transport of an LHRH agonist. Pharmaceutical research 20040601
Enhancement of embryo developmental potential by a single administration of GnRH agonist at the time of implantation. Human reproduction (Oxford, England) 20040501
A life-threatening event: uterine cervical arteriovenous malformation. Obstetrics and gynecology 20040501
Accelerated versus slowly progressive forms of puberty in girls with precocious and early puberty. Gonadotropin suppressive effect and final height obtained with two different analogs. Journal of pediatric endocrinology & metabolism : JPEM 20040501
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility. Endocrinology 20040401
Premature luteinization defined as progesterone estradiol ratio >1 on hCG administration day seems to adversely affect clinical outcome in long gonadotropin-releasing hormone agonist cycles. The journal of obstetrics and gynaecology research 20040401
Early and late hormonal responses to the microdose gonadotropin-releasing hormone agonist in normal menstruating women. Fertility and sterility 20040401
Effect of nonsteroidal antiandrogen monotherapy versus castration therapy on neuroendocrine differentiation in prostate carcinoma. Urology 20040301
Triptorelin versus cetrorelix in intracytoplasmic sperm injection cycles in women with a single ovary. European journal of obstetrics, gynecology, and reproductive biology 20040210
Antagonists of growth hormone-releasing hormone (GH-RH) enhance tumour growth inhibition induced by androgen deprivation in human MDA-Pca-2b prostate cancers. European journal of cancer (Oxford, England : 1990) 20040201
Adjuvant cytotoxic and endocrine therapy in pre- and postmenopausal patients with breast cancer and one to nine infiltrated nodes: five-year results of the Hellenic Cooperative Oncology Group randomized HE 10/92 study. American journal of clinical oncology 20040201
Equivalence of the 3-month and 28-day formulations of triptorelin with regard to achievement and maintenance of medical castration in women with endometriosis. Fertility and sterility 20040201
Effect of deslorelin implants on follicular development, parturition and post-partum oestrus in the tammar wallaby (Macropus eugenii). Reproduction (Cambridge, England) 20040201
Relationship between gonadotropin releasing hormone agonist dosage and in vitro fertilization outcome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20040201
Induction of ovulation in nonlactating dairy cows and heifers using different doses of a deslorelin implant. Theriogenology 20040115
Effect of a deslorelin implant in a timed artificial insemination protocol on follicle development, luteal function and reproductive performance of lactating dairy cows. Theriogenology 20040115
Pituitary and gonadal effects of GnRH (gonadotropin releasing hormone) analogues in two peripubertal female rat models. Pediatric research 20040101
Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. The Journal of clinical endocrinology and metabolism 20040101
Combination of LHRH analog with somatostatin analog and dexamethasone versus chemotherapy in hormone-refractory prostate cancer: a randomized phase II study. Urology 20040101
Protocol combining GnRH agonists and GnRH antagonists for rapid suppression and prevention of gonadal damage during cytotoxic therapy. European journal of gynaecological oncology 20040101
Luteinizing hormone-releasing hormone (LHRH) inhibits apoptosis induced by cytotoxic agent and UV-light but not apoptosis mediated through CD95 in human ovarian and endometrial cancer cells. Anticancer research 20040101
Pharmacodynamic equivalence of a decapeptyl 3-month SR formulation with the 28-day SR formulation in patients with advanced prostate cancer. Hormone research 20040101
Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome. The Journal of clinical endocrinology and metabolism 20031201
Alopecia in a premenopausal breast cancer woman treated with letrozole and triptorelin. Annals of oncology : official journal of the European Society for Medical Oncology 20031101
2-methoxyestradiol strongly inhibits human uterine sarcomatous cell growth. Gynecologic oncology 20031101
Gonadotropin-releasing hormone (GnRH)-antagonist versus GnRH-agonist in ovarian stimulation of poor responders undergoing IVF. Journal of assisted reproduction and genetics 20031101
The effect of GnRH analogs on urinary incontinence after ablation of the ovaries in dogs. Theriogenology 20031015
Absorbable deslorelin implants (Ovuplant) prolong postpartum anestrus in early ovulating dairy cows. Theriogenology 20031015
Effects of a Gonadotropin-Releasing Hormone agonist and Follicle Stimulating Hormone on the incidence of apoptosis in human luteinized granulosa cells. European journal of obstetrics, gynecology, and reproductive biology 20030910
Comparison of the response to ovarian stimulation between women with one ovary and those with two ovaries, in a program of ICSI/ET. Acta obstetricia et gynecologica Scandinavica 20030901
Effects of combined gonadotropin-releasing hormone agonist and growth hormone therapy on adult height in precocious puberty: a further contribution. Journal of pediatric endocrinology & metabolism : JPEM 20030901
Depot GnRH agonist versus the single dose GnRH antagonist regimen (cetrorelix, 3 mg) in patients undergoing assisted reproduction treatment. Reproductive biomedicine online 20030901
A complete remission with androgen-deprivation therapy in a recurrent androgen receptor-expressing adenocarcinoma of the parotid gland. Annals of oncology : official journal of the European Society for Medical Oncology 20030801
Comparative efficacy of triptorelin pamoate and leuprolide acetate in men with advanced prostate cancer. BJU international 20030801
Pharmacotherapy of paraphilias with long-acting agonists of luteinizing hormone-releasing hormone: a systematic review. The Journal of clinical psychiatry 20030801
[Effect of low-dose triptorelin on pituitary down-regulation for patients undergoing in vitro fertilization and embryo transfer]. Zhonghua nan ke xue = National journal of andrology 20030801
GnRH agonist treatment before total laparoscopic hysterectomy for large uteri. The Journal of the American Association of Gynecologic Laparoscopists 20030801
The human chorionic gonadotropin test is more powerful than the gonadotropin-releasing hormone agonist test to discriminate male isolated hypogonadotropic hypogonadism from constitutional delayed puberty. European journal of endocrinology 20030701
Actions of GnRH antagonists on IGF-II, IGF-binding protein-2 and pregnancy-associated plasma protein-A in human granulosa-lutein cells. European journal of endocrinology 20030701
Doppler-ultrasound as a predictor of uterine fibroid response to GnRH therapy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20030701
New drugs 2003, part II. Nursing 20030701
Gonadotropin-releasing hormone agonist treatment before abdominal myomectomy: a controlled trial. Fertility and sterility 20030601
Impact of the gonadotropin-releasing hormone antagonist in oocyte donation cycles. Fertility and sterility 20030601
The use of score tests for inference on variance components. Biometrics 20030601
Variation in chromogranin A serum levels during intermittent versus continuous androgen deprivation therapy for prostate adenocarcinoma. The Prostate 20030515
Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin. Fertility and sterility 20030501
Pathways and kinetics of deslorelin degradation in an airway epithelial cell line (Calu-1). Pharmaceutical research 20030501
Effects of deslorelin acetate implants in horses: single implants in stallions and steroid-treated geldings and multiple implants in mares. Journal of animal science 20030501
Prospective evaluation of two stimulation protocols for low responders who were undergoing in vitro fertilization-embryo transfer. Fertility and sterility 20030401
Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. The New England journal of medicine 20030306
Is treatment with a luteinizing hormone-releasing hormone agonist justified in short adolescents? The New England journal of medicine 20030306
Sperm to zona pellucida binding depends on the use of a gonadotropin-releasing hormone agonist or a gonadotropin-releasing hormone antagonist. Fertility and sterility 20030301
Bone mass at final height in precocious puberty after gonadotropin-releasing hormone agonist with and without calcium supplementation. The Journal of clinical endocrinology and metabolism 20030301
Profound luteinizing hormone suppression induces a deleterious follicular environment during assisted reproduction technology. Fertility and sterility 20030201
Eligard: leuprolide acetate in a novel sustained-release delivery system. Urology 20030201
The use of clomiphene citrate/human menopausal gonadotrophins in conjunction with GnRH antagonist in an IVF/ICSI program is not a cost effective protocol. Acta obstetricia et gynecologica Scandinavica 20030101
Human growth hormone and gonadotropin releasing hormone analog combination therapy increases predicted height in short normal girls. Clinical pediatrics 20030101
Antiprolactinemic approach in the treatment of metastatic breast cancer: a phase II study of polyneuroendocrine therapy with LHRH-analogue, tamoxifen and the long-acting antiprolactinemic drug cabergoline. Anticancer research 20030101
[Endometriosis and diferelin]. Akusherstvo i ginekologiia 20030101
Role of gonadotropin-releasing hormone (GnRH) in ovarian cancer. Reproductive biology and endocrinology : RB&E 20030101
GnRH agonist administration after embryo transfer, in long protocol stimulated cycles, prevents ovarian hyperstimulation syndrome. A report of five cases. In vivo (Athens, Greece) 20030101
Use of a new drug delivery formulation of the gonadotrophin-releasing hormone analogue Deslorelin for reversible long-term contraception in male dogs. Reproduction, fertility, and development 20030101
Use of GnRH agonist implants for long-term suppression of fertility in extensively managed heifers and cows. Animal reproduction science 20021216
Pluronic F127 gel formulations of deslorelin and GnRH reduce drug degradation and sustain drug release and effect in cattle. Journal of controlled release : official journal of the Controlled Release Society 20021213
[Medical treatment in abnormal uterine bleeding: evaluation of a GnRH therapy versus danazol therapy in perimenopausal women]. Minerva ginecologica 20021201
Control of ovulation with a GnRH agonist after superstimulation of follicular growth in buffalo: fertilization and embryo recovery. Theriogenology 20021201
Differential requirement for pulsatile LH during the follicular phase and exposure to the preovulatory LH surge for oocyte fertilization and embryo development in cattle. Theriogenology 20021201
Comparison of leuprolide acetate and triptorelin in assisted reproductive technology cycles: a prospective, randomized study. Fertility and sterility 20021201
Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. Endocrinology 20021101
Pituitary responsiveness to GnRH in mares following deslorelin acetate implantation to hasten ovulation. Journal of animal science 20021001
Ovarian hyperstimulation-like syndrome after administration of triptorelin to a woman with endometriosis. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20021001
Removal of deslorelin (Ovuplant) implant 48 h after administration results in normal interovulatory intervals in mares. Theriogenology 20020901
Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays. Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association 20020801
Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation. International journal of impotence research 20020801
Progesterone clearance rate in lactating dairy cows with two levels of dry matter and metabolisable energy intakes. Animal reproduction science 20020715
Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer? Urology 20020701
Deslorelin acetate (Ovuplant) therapy in cycling mares: effect of implant removal on FSH secretion and ovarian function. Equine veterinary journal 20020701
Strategies to optimize reproductive efficiency by regulation of ovarian function. Domestic animal endocrinology 20020701
Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty. Indian pediatrics 20020701
Effects of deslorelin or hCG administration on reproductive performance in first postpartum estrus mares. Theriogenology 20020701
[Comparative study of the efficiency of gonadotrope releasing hormone (GnRH) analogs for the treatment of endometriosis]. Orvosi hetilap 20020616
Inhibitory effects of a luteinizing hormone-releasing hormone agonist on basal and epidermal growth factor-induced cell proliferation and metastasis-associated properties in human epidermoid carcinoma A431 cells. International journal of cancer 20020601
Differential effect of gonadotropin-releasing hormone analogue treatment on estrogen levels and sulfatase activity in uterine leiomyoma and myometrium. Fertility and sterility 20020601
Luteinizing hormone-releasing hormone induces JunD-DNA binding and extends cell cycle in human ovarian cancer cells. Biochemical and biophysical research communications 20020531
Use of GnRH agonist and human chorionic gonadotrophin tests for differentiating constitutional delayed puberty from gonadotrophin deficiency in boys. Clinical endocrinology 20020501
Dienogest is as effective as triptorelin in the treatment of endometriosis after laparoscopic surgery: results of a prospective, multicenter, randomized study. Fertility and sterility 20020401
Embryo recovery and pregnancy rates after the delay of ovulation and fixed time insemination in superstimulated beef cows. Theriogenology 20020401
Reproductive responses of early postpartum dairy cattle to continuous treatment with a GnRH agonist (deslorelin) for 28 days to delay the resumption of ovulation. Animal reproduction science 20020315
Temporary suppression of pulsatile LH release following a single injection of a GnRH agonist (deslorelin) in ovariectomised Holstein dairy cows. Animal reproduction science 20020315
Restoration of LH output and 17beta-oestradiol responsiveness in acutely ovariectomised holstein dairy cows pre-treated with a GnRH agonist (deslorelin) for 10 days. Animal reproduction science 20020315
Expression of gonadotropin-releasing hormone II (GnRH-II) receptor in human endometrial and ovarian cancer cells and effects of GnRH-II on tumor cell proliferation. The Journal of clinical endocrinology and metabolism 20020301
A study of the binding between polymers and peptides, using affinity capillary electrophoresis, applied to polymeric drug delivery systems. Electrophoresis 20020301
Treatment of central precocious puberty. Best practice & research. Clinical endocrinology & metabolism 20020301
Expression of receptors for luteinizing hormone-releasing hormone in human ovarian and endometrial cancers: frequency, autoregulation, and correlation with direct antiproliferative activity of luteinizing hormone-releasing hormone analogues. American journal of obstetrics and gynecology 20020201
Clinical and endocrine effects of ovulation induction with FSH and hCG supplementation in low responders in the midfollicular phase. A pilot study. The Journal of reproductive medicine 20020201
Use of gonadotrophin-releasing hormone agonists to trigger ovulation. Human fertility (Cambridge, England) 20020201
The gonadotrophin-releasing hormone antagonist ganirelix--history and introductory data. Human fertility (Cambridge, England) 20020201
The effects of varying doses of T on insulin sensitivity, plasma lipids, apolipoproteins, and C-reactive protein in healthy young men. The Journal of clinical endocrinology and metabolism 20020101
Induction of contraception in some African wild carnivores by downregulation of LH and FSH secretion using the GnRH analogue deslorelin. Reproduction (Cambridge, England) Supplement 20020101
The effects of add-back therapy with tibolone on myoma uteri. Clinical and experimental obstetrics & gynecology 20020101
Parenteral estrogen versus combined androgen deprivation in the treatment of metastatic prostatic cancer -- Scandinavian Prostatic Cancer Group (SPCG) Study No. 5. Scandinavian journal of urology and nephrology 20020101
Structure-function studies of linear and cyclized peptide antagonists of the GnRH receptor. Biochemical and biophysical research communications 20011207
Management and fertility of mares bred with frozen semen. Animal reproduction science 20011203
Effects of androgen manipulation on postprandial triglyceridaemia, low-density lipoprotein particle size and lipoprotein(a) in men. Atherosclerosis 20011201
Levels of estrogen and progesterone receptors in the myometrium and leiomyoma tissue after suppression of estrogens with gonadotropin releasing hormone analogs. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20011201
Protein kinase C-independent stimulation of activator protein-1 and c-Jun N-terminal kinase activity in human endometrial cancer cells by the LHRH agonist triptorelin. European journal of endocrinology 20011101
Physical and chemical enhancement of transdermal delivery of triptorelin. Pharmaceutical research 20011101
Interaction of [D-Trp6, Des-Gly10] LHRH ethylamide and hydroxy propyl beta-cyclodextrin (HPbetaCD): thermodynamics of interaction and protection from degradation by alpha-chymotrypsin. Pharmaceutical development and technology 20011101
The effect of pubertal delay by GnRH agonist in GH-deficient children on final height. The Journal of clinical endocrinology and metabolism 20011001
Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. The Journal of clinical endocrinology and metabolism 20011001
Suppression of ovarian progesterone production in dairy cows using an implant of GnRH-agonist (deslorelin) for the purpose of evaluating progesterone metabolism [corrected]. Australian veterinary journal 20011001
Follow-up of children and young adults after GnRH-agonist therapy or central precocious puberty. Journal of endocrinological investigation 20011001
The effect of level of feed intake on progesterone clearance rate by measuring faecal progesterone metabolites in grazing dairy cows. Animal reproduction science 20010915
Sexual precocity in boys: accelerated versus slowly progressive puberty gonadotropin-suppressive therapy and final height. The Journal of clinical endocrinology and metabolism 20010901
Hormonal regulation of peripheral benzodiazepine receptor binding properties is mediated by subunit interaction. Biochemistry 20010828
Prospective evaluation of hot flashes during treatment with parenteral estrogen or complete androgen ablation for metastatic carcinoma of the prostate. The Journal of urology 20010801
The development of an oocyte-containing follicle during gonadotrophin-releasing hormone agonist administration. Human reproduction (Oxford, England) 20010801
Increased progesterone/estradiol ratio in the late follicular phase could be related to low ovarian reserve in in vitro fertilization-embryo transfer cycles with a long gonadotropin-releasing hormone agonist. Fertility and sterility 20010801
Effect of an implant containing the GnRH agonist deslorelin on secretion of LH, ovarian activity and milk yield of postpartum dairy cows. Theriogenology 20010801
Effect of reduced dose of triptorelin at the start of ovarian stimulation on the outcome of IVF: a randomized study. Human reproduction (Oxford, England) 20010701
Estrogen 'add-back' and lipid profile during GnRH agonist (triptorelin) therapy. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics 20010701
A randomized controlled trial of three years growth hormone and gonadotropin-releasing hormone agonist treatment in children with idiopathic short stature and intrauterine growth retardation. The Journal of clinical endocrinology and metabolism 20010701
Actions of gonadotropin-releasing hormone antagonists on steroidogenesis in human granulosa lutein cells. European journal of endocrinology 20010601
Pubertal disorders in inv dup(15) syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20010601
Leuprorelin and triptorelin: new indication. Preoperative treatment of uterine leiomyoma: no proven value. Prescrire international 20010601
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells. Molecular and cellular endocrinology 20010515
Autoregulation of the gonadotropin-releasing hormone (GnRH) system during puberty: effects of antagonistic versus agonistic GnRH analogs in a female rat model. The Journal of endocrinology 20010501
[Decapeptyl (triptorelin) in the treatment of endometriosis genitalis externa]. Ginekologia polska 20010501
Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Human reproduction (Oxford, England) 20010401
Dose-finding study for the use of long-acting gonadotrophin-releasing hormone analogues prior to ovarian stimulation for IVF. Human reproduction (Oxford, England) 20010301
Effect of deslorelin acetate on gonadotropin secretion and ovarian follicle development in cycling mares. Journal of the American Veterinary Medical Association 20010301
Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. International journal of pharmaceutics 20010219
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study. Anti-cancer drugs 20010201
[Comparison of different protocols of ovulation induction, by GnRH agonists and chorionic gonadotropin]. Gynecologie, obstetrique & fertilite 20010201
[Anemia and neoadjuvant hormone therapy in radical surgery of localized cancer of the prostate]. Actas urologicas espanolas 20010201
Use of oocyte transfer in a commercial breeding program for mares with reproductive abnormalities. Journal of the American Veterinary Medical Association 20010101
Long-term remission of ovarian hyperandrogenism after short-term treatment with a gonadotropin-releasing hormone agonist. Fertility and sterility 20010101
Ovarian rescue/protection from chemotherapeutic agents. Journal of the Society for Gynecologic Investigation 20010101
Luteinzing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. The Journal of clinical endocrinology and metabolism 20010101
Sex hormone replacement therapy reverses decreased venous distensibility in pharmacologically ovariectomized rats. Menopause (New York, N.Y.) 20010101
Investigation of synthetic peptide hormones by liquid chromatography coupled to pneumatically assisted electrospray ionization mass spectrometry: analysis of a synthesis crude of peptide triptorelin. Rapid communications in mass spectrometry : RCM 20010101
A practical GnRH analogue (triptorelin) stimulation test to distinguish constitutional delay of puberty from hypogonadotropic hypogonadism in prepubertal boys. The Turkish journal of pediatrics 20010101
[Diferelin treatment of primary local and generalized cancer of the prostate]. Urologiia (Moscow, Russia : 1999) 20010101
Use of a GnRH analogue implant to produce reversible long-term suppression of reproductive function in male and female domestic dogs. Journal of reproduction and fertility. Supplement 20010101
Suppression of the oestrous responses of bitches to the GnRH analogue deslorelin by progestin. Journal of reproduction and fertility. Supplement 20010101
Efficacy of the GnRH analogue deslorelin for suppression of oestrous cycles in cats. Journal of reproduction and fertility. Supplement 20010101
Control of reproduction and sex related behaviour in exotic wild carnivores with the GnRH analogue deslorelin: preliminary observations. Journal of reproduction and fertility. Supplement 20010101
Excretion rate of progesterone in milk and faeces in lactating dairy cows with two levels of milk yield. Reproduction, nutrition, development 20010101
Conversion of nested reverse-transcriptase polymerase chain reaction from positive to negative status at peripheral blood during androgen ablation therapy is associated with long progression-free survival in stage D2 prostate cancer patients. Anticancer research 20010101
A phase II trial with new triptorelin sustained release formulations in prostatic carcinoma. International urology and nephrology 20010101
Hormonal and clinical effects of GnRH agonist alone, or in combination with a combined oral contraceptive or flutamide in women with severe hirsutism. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology 20001201
Residues within transmembrane helices 2 and 5 of the human gonadotropin-releasing hormone receptor contribute to agonist and antagonist binding. Molecular endocrinology (Baltimore, Md.) 20000701
Pharmacokinetics and pharmacodynamics of GnRH agonists: clinical implications in pediatrics. Journal of pediatric endocrinology & metabolism : JPEM 20000701
Uterine adenocarcinoma after GnRH agonist treatment. Archives of gynecology and obstetrics 20000201
Revisiting gonadotrophin-releasing hormone agonist protocols and management of poor ovarian responses to gonadotrophins. Human reproduction update 19980101
Hepatocellular carcinoma during hormonotherapy for prostatic cancer. American journal of clinical oncology 19941001
Programmed cell death (apoptosis) in pancreatic cancers of hamsters after treatment with analogs of both luteinizing hormone-releasing hormone and somatostatin. Proceedings of the National Academy of Sciences of the United States of America 19890301
Tryptophan reduction and histidine racemization during deprotection by catalytic transfer hydrogenation of an analog of the luteinizing hormone releasing factor. International journal of peptide and protein research 19880401
Somatostatin analogs as adjuncts to agonists of luteinizing hormone-releasing hormone in the treatment of experimental prostate cancer. Proceedings of the National Academy of Sciences of the United States of America 19871001
D-Trp6-luteinizing hormone-releasing hormone inhibits sulpiride-induced hyperprolactinemia in normal men. The Journal of clinical endocrinology and metabolism 19870801
Treatment of nitrosamine-induced pancreatic tumors in hamsters with analogs of somatostatin and luteinizing hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America 19870201
D-Trp-6-luteinizing hormone-releasing hormone inhibits hyperprolactinemia in female rats. Endocrinology 19850601
Inhibition of growth of a prolactin and growth hormone-secreting pituitary tumor in rats by D-tryptophan-6 analog of luteinizing hormone-releasing hormone. Proceedings of the National Academy of Sciences of the United States of America 19850201
Inhibition of growth of pancreatic carcinomas in animal models by analogs of hypothalamic hormones. Proceedings of the National Academy of Sciences of the United States of America 19840101
Properties